Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tyrosine kinases as targets for cancer therapy.

The New England journal of medicine - 14 Jul 2005

Krause Daniela S, Van Etten Richard A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to fms-Like Tyrosine Kinase 3
Share to Hematologic Neoplasms
Share to Imatinib Mesylate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Piperazines

Share to Protein-Tyrosine Kinases

Share to Pyrimidines

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 16014887
DOI: 10.1056/NEJMra044389

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tyrosine kinases as targets for cancer therapy.PMID 16014887Read ↗

Protein Kinases as Targets for Cancer TreatmentSemantic proximity Read ↗

Kinase-targeted cancer therapies: progress, challenges and future directionsSemantic proximity Read ↗

Receptor tyrosine kinases as targets for anticancer drugs.Semantic proximity Read ↗

Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancerSemantic proximity Read ↗

Protein tyrosine kinases and cancer.Semantic proximity Read ↗

Rational therapeutic intervention in cancer: kinases as drug targets.Semantic proximity Read ↗

Oncogenic tyrosine kinases.Semantic proximity Read ↗

Targeting tyrosine kinases in cancer: the second wave.Semantic proximity Read ↗

A New Challenging and Promising Era of Tyrosine Kinase InhibitorsSemantic proximity Read ↗

Kinase inhibitors for precision therapy of triple-negative breast cancer: Progress, challenges, and new perspectives on targeting this heterogeneous diseaseSemantic proximity Read ↗

Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors.Semantic proximity Read ↗

[Kinase inhibitors].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.